ARTICLE | Company News
Pfizer sales and marketing update
June 11, 2012 7:00 AM UTC
Pfizer's Pfizer Canada Inc. subsidiary launched Toviaz fesoterodine 4 and 8 mg tablets in Canada for once-daily treatment of overactive bladder (OAB). The wholesale acquisition cost is $2.43 per tabl...